BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33130005)

  • 1. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
    Mousavi SZ; Rahmanian M; Sami A
    Infect Genet Evol; 2020 Dec; 86():104610. PubMed ID: 33130005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
    Le BL; Andreoletti G; Oskotsky T; Vallejo-Gracia A; Rosales R; Yu K; Kosti I; Leon KE; Bunis DG; Li C; Kumar GR; White KM; García-Sastre A; Ott M; Sirota M
    Sci Rep; 2021 Jun; 11(1):12310. PubMed ID: 34112877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
    Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
    Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-specific or personalized treatment for COVID-19: rationale, evidence, and potential candidates.
    Mousavi SZ; Rahmanian M; Sami A
    Funct Integr Genomics; 2022 Jun; 22(3):429-433. PubMed ID: 35290538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
    Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
    Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Omics Strategy for Translational Bioinformatics and Rapid COVID-19 Drug Repurposing.
    Revikumar A
    OMICS; 2023 Mar; 27(3):109-115. PubMed ID: 36854133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.
    Chen WY; Fang ZX; Lv XD; Zhou QH; Yao M; Deng M
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3122-3131. PubMed ID: 33877681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19.
    Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z
    Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
    O'Donovan SM; Imami A; Eby H; Henkel ND; Creeden JF; Asah S; Zhang X; Wu X; Alnafisah R; Taylor RT; Reigle J; Thorman A; Shamsaei B; Meller J; McCullumsmith RE
    Sci Rep; 2021 Feb; 11(1):4495. PubMed ID: 33627767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
    Mirabelli C; Wotring JW; Zhang CJ; McCarty SM; Fursmidt R; Pretto CD; Qiao Y; Zhang Y; Frum T; Kadambi NS; Amin AT; O'Meara TR; Spence JR; Huang J; Alysandratos KD; Kotton DN; Handelman SK; Wobus CE; Weatherwax KJ; Mashour GA; O'Meara MJ; Chinnaiyan AM; Sexton JZ
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34413211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
    Zeng X; Song X; Ma T; Pan X; Zhou Y; Hou Y; Zhang Z; Li K; Karypis G; Cheng F
    J Proteome Res; 2020 Nov; 19(11):4624-4636. PubMed ID: 32654489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
    Tomazou M; Bourdakou MM; Minadakis G; Zachariou M; Oulas A; Karatzas E; Loizidou EM; Kakouri AC; Christodoulou CC; Savva K; Zanti M; Onisiforou A; Afxenti S; Richter J; Christodoulou CG; Kyprianou T; Kolios G; Dietis N; Spyrou GM
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34009288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
    Sharma K; Morla S; Goyal A; Kumar S
    Life Sci; 2020 Oct; 259():118169. PubMed ID: 32738360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.